| |
| |
|
| Insider
Information: |
Arbuckle Stuart A |
| Relationship: |
Director |
| City: |
Cambridge, |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
62,795 |
|
|
Indirect Shares
|
140 |
|
|
| Direct
Value |
$21,012,430 |
|
|
|
Indirect Value
|
$59,189 |
|
|
| Total
Shares |
62,935 |
|
|
| Total
Value |
$21,071,619 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vertex Pharmaceuticals Inc |
VRTX |
EVP, COO |
2024-02-26 |
49,691 |
2024-02-26 |
140 |
Premium* |
|
|
Dare Bioscience Inc |
DARE |
Director |
2017-01-03 |
13,104 |
2016-10-03 |
0 |
Premium* |
|
|
Immunogen Inc |
IMGN |
Director |
2024-02-12 |
0 |
2023-06-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
191 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DARE |
Dare Bioscience Inc |
Director |
– • – |
2016-10-03 |
4 |
A |
$1.02 |
$5,750 |
D/D |
5,637 |
5,637 |
0 |
- |
|
| DARE |
Dare Bioscience Inc |
Director |
– • – |
2017-01-03 |
4 |
A |
$0.77 |
$5,750 |
D/D |
7,467 |
13,104 |
0 |
- |
|
| IMGN |
Immunogen Inc |
|
– • – |
2023-06-30 |
4 |
A |
$18.87 |
$13,115 |
D/D |
695 |
4,112 |
0 |
- |
|
| IMGN |
Immunogen Inc |
|
– • – |
2023-09-29 |
4 |
A |
$15.87 |
$13,124 |
D/D |
827 |
4,939 |
0 |
- |
|
| IMGN |
Immunogen Inc |
|
– • – |
2023-12-29 |
4 |
A |
$29.65 |
$13,105 |
D/D |
442 |
5,381 |
0 |
- |
|
| IMGN |
Immunogen Inc |
Director |
– • – |
2024-02-12 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,381) |
0 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
• – – |
2012-09-04 |
4 |
A |
$0.01 |
$397 |
D/D |
39,667 |
39,667 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
• – – |
2013-02-05 |
4 |
A |
$0.01 |
$121 |
D/D |
12,084 |
51,751 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
• – – |
2013-07-29 |
4 |
AS |
$79.87 |
$27,715 |
D/D |
(347) |
51,751 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
• – – |
2013-10-01 |
4 |
AS |
$75.73 |
$947,166 |
D/D |
(12,417) |
39,334 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
• – – |
2013-12-12 |
4 |
AS |
$65.47 |
$197,785 |
D/D |
(3,021) |
36,718 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
• – – |
2014-02-05 |
4 |
A |
$0.01 |
$207 |
D/D |
20,700 |
57,418 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
• – – |
2014-09-19 |
4 |
AS |
$100.00 |
$5,552,100 |
D/D |
(55,521) |
54,681 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
• – – |
2014-09-19 |
4 |
OE |
$45.11 |
$2,601,285 |
D/D |
52,500 |
110,202 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
• – – |
2014-10-01 |
4 |
AS |
$106.32 |
$1,337,377 |
D/D |
(12,417) |
42,264 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
• – – |
2014-10-30 |
4 |
A |
$0.01 |
$750 |
D/D |
75,000 |
117,264 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
• – – |
2014-11-05 |
4 |
AS |
$112.07 |
$478,121 |
D/D |
(4,250) |
117,264 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
• – – |
2014-11-05 |
4 |
OE |
$45.11 |
$191,718 |
D/D |
4,250 |
121,514 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
• – – |
2015-02-03 |
4 |
A |
$0.01 |
$207 |
D/D |
20,700 |
138,270 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
• – – |
2015-04-27 |
4 |
OE |
$45.11 |
$3,000,404 |
D/D |
50,875 |
188,995 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
• – – |
2015-04-27 |
4 |
GD |
$0.00 |
$0 |
D/D |
150 |
138,120 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
• – – |
2015-04-27 |
4 |
AS |
$127.49 |
$7,952,758 |
D/D |
(61,480) |
127,515 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
• – – |
2015-05-15 |
4 |
AS |
$123.85 |
$18,330 |
D/D |
(148) |
127,515 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
• – – |
2015-08-05 |
4 |
AS |
$140.51 |
$2,801,202 |
D/D |
(19,828) |
127,515 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
• – – |
2015-08-05 |
4 |
OE |
$45.11 |
$1,168,141 |
D/D |
19,828 |
147,343 |
0 |
- |
|
191 Records found
|
|
Page 1 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
